Browsing Tag
nanomedicine
3 posts
Argent Biopharma (ASX: RGT) shares rise 7.69% as U.S. in vivo study validates ArtemiC efficacy in Alzheimer’s model
Argent Biopharma gains 7.69% after U.S. in vivo Alzheimer’s study validates ArtemiC’s plaque-reducing effects. Read more on RGT’s strategy and market outlook.
What is gold nanorod therapy and how does Sona Nanotech plan to use it to treat late-stage melanoma patients?
Sona Nanotech’s gold nanorod cancer therapy is heading to human trials. Learn how its CTAB-free Targeted Hyperthermia Therapy works and what’s next for melanoma care.
Sona Nanotech set to launch first human trial of its gold nanoparticle cancer therapy
Sona Nanotech receives ethics approval to begin first-in-human melanoma trial using gold nanorod-based hyperthermia therapy. Patient dosing to start soon.